Doç. Dr. AHMET EKEN

Yayın Ağı

Makaleler 67

1. Lycopene Supplemented Mediterranean Diet Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice and Changes Intestinal Microbiome

Atuk Kahraman T., Yılmaz M., Aslan K., Canatan H., Kara A., Nalbantoğlu Ö. U., et al.

Journal of Neuroimmune Pharmacology , cilt.20, sa.1, 2025 (SCI-Expanded, Scopus)

2. **A novel loss of function mutation in the HAVCR2 gene in a patient diagnosed with Hodgkin's lymphoma**

Erdem S., YILMAZ E., ÖZCAN A., Canatan A. N., Bisgin A., Dogan M. E., et al.

IMMUNOLOGIC RESEARCH , cilt.73, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Changes in Tissue-Specific Innate Lymphoid Cell Populations during Rat Development.

Yiğit H., Erdem Ş., Uslu İ. N., Taştan M., Houran M. A., Demir B. Ş., et al.

Cells, tissues, organs , ss.1-28, 2025 (SCI-Expanded, Scopus)

4. Mast Cells Are Intrinsically Primed for Degranulation in DOCK8 Deficiency

Samanas N. B., Miralda I., Camp N., Sachen J., Puryear V., Shah L., et al.

Allergy: European Journal of Allergy and Clinical Immunology , cilt.80, sa.9, ss.2650-2653, 2025 (SCI-Expanded, Scopus)

5. The number and frequency of mucosal-associated invariant T (MAIT), γδ T, and innate lymphoid cells (ILCs) altered in patients with type I Gaucher disease

Uzen R., Bayram F., Dursun H., Kardaş F., Çakır M., Cücer N., et al.

HUMAN IMMUNOLOGY , cilt.86, sa.3, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months

YILMAZ S., EKEN A., SEZER Z., Bagci B. S., Erdem S., Sarikaya M. D., et al.

FRONTIERS IN MEDICINE , cilt.12, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Tumor Suppressor and Oncogenic miRNA Expressions in Patients with Type I Gaucher Disease and Carriers

Üzen R., Bayram F., Dursun H., Kardas F., Cakir M., Hasan Sohel M. M., et al.

MICRORNA , cilt.14, sa.3, ss.246-253, 2025 (ESCI) Sürdürülebilir Kalkınma

8. Clinical spectrum of primary hemophagocytic lymphohistiocytosis: experience of reference centers in Central and Southeast Anatolia

Akyol Ş., Yılmaz E., Tokgöz H., Karaman K., Pekpak E., Özcan A., et al.

ANNALS OF HEMATOLOGY , cilt.104, sa.1, ss.123-130, 2025 (SCI-Expanded, Scopus)

9. DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans

Azizoglu Z. B., Babayeva R., Haskologlu Z. S., Acar M. B., Ayaz-Guner S., Okus F. Z., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , cilt.44, sa.8, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Thiamine status and genes encoding intestinal thiamine transporters and transcription factors in obese subjects

Dizdar O. S., Erdem S., Deliktas E. D., Dogan S., GÜNDOĞAN K., Genton L., et al.

Nutrition, Metabolism and Cardiovascular Diseases , cilt.34, sa.10, ss.2369-2377, 2024 (SCI-Expanded, Scopus)

11. **Investigation of immunomodulatory and cytotoxic effects of shed snake skin (Elaphe sauromates) extract**

Sinmez Ç. Ç., Tüfekçi E., Demir B. Ş., Eken A., Guneş V., Ekici S., et al.

FRONTIERS IN PHARMACOLOGY , cilt.15, 2024 (SCI-Expanded, Scopus)

12. Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants

GÖK V., LEBLEBİSATAN G., Gokcebay D. G., GÜLER S., Dogan M. E., Bozdogan S. T., et al.

BRITISH JOURNAL OF HAEMATOLOGY , cilt.205, sa.1, ss.236-242, 2024 (SCI-Expanded, Scopus)

13. Alantolactone ameliorates graft versus host disease in mice

Odabas G. P., Aslan K., Suna P. A., Kendirli P. K., Erdem Ş., Çakır M., et al.

INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.128, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. A Novel Biallelic LCK Variant Resulting in Profound T-Cell Immune Deficiency and Review of the Literature

Lanz A., Erdem S., ÖZCAN A., CEYLANER G., CANSEVER M., CEYLANER S., et al.

Journal of Clinical Immunology , cilt.44, sa.1, 2024 (SCI-Expanded, Scopus)

15. A case of autoimmune lymphoproliferative syndrome with a novel de novo FAS variant

Özçelik F., Aslan K., Gök V., Ari M. B., Özcan A., Eken A., et al.

Pediatric Hematology and Oncology , cilt.41, sa.4, ss.301-309, 2024 (SCI-Expanded, Scopus)

16. Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension

ŞAHİN A., KOÇYİĞİT İ., ASLAN K., Eroglu E., DEMİRAY A., EKEN A.

Clinical and Experimental Medicine , cilt.23, sa.7, ss.3631-3640, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Changes in Mucosa-Associated Invariant T Cells (Mait), Assocıated Cytokines, and MR-1+ Cell Number And Phenotype In The Peripheral Blood of Pediatric ITP Patients with and without Eltrombopag Therapy

Eken A., Çil M., Azizoglu Z. B., Üzen R., Asaad N. N., Calık S., et al.

Hematology, Transfusion and Cell Therapy , cilt.45, ss.17-18, 2023 (ESCI, Scopus) Sürdürülebilir Kalkınma

18. Defective Treg generation and increased type 3 immune response in leukocyte adhesion deficiency 1

Erdem S., Haskoloğlu Z. Ş., Haliloglu Y., Celikzencir H., Arik E., Keskin O., et al.

Clinical Immunology , cilt.253, 2023 (SCI-Expanded, Scopus)

19. The Beneficial Clinical Effects of Teriflunomide in Experimental Autoimmune Myasthenia Gravis and the Investigation of the Possible Immunological Mechanisms

KÖSEOĞLU E., SUNGUR N., MUHTAROĞLU S., ZARARSIZ G., EKEN A.

CELLULAR AND MOLECULAR NEUROBIOLOGY , cilt.43, sa.5, ss.2071-2087, 2023 (SCI-Expanded, Scopus)

20. Dedicator of cytokinesis 8 (DOCK8) is a negative regulator of skin mast cell function

Molina I. M., Samanas N. B., Seo A. J., Foronda J., Deutsch G. H., BARIŞ S., et al.

JOURNAL OF IMMUNOLOGY , cilt.210, sa.1, 2023 (SCI-Expanded, Scopus)

21. Characterization of peripheral blood T follicular helper (TFH) cells in patients with type 1 Gaucher disease and carriers

Uzen R., BAYRAM F., DURSUN H., KARDAŞ F., Çakır M., CÜCER N., et al.

Blood Cells, Molecules, and Diseases , cilt.100, 2023 (SCI-Expanded, Scopus)

22. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.

Leiding J. W., Vogel T. P., Santarlas V. G. J., Mhaskar R., Smith M. R., Carisey A., et al.

The Journal of allergy and clinical immunology , cilt.151, sa.4, ss.1081-1095, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities

Heydari Z., Peshkova M., GÖNEN Z. B., Coretchi I., Eken A., YAY A. H., et al.

Journal of Molecular Medicine , cilt.101, sa.1-2, ss.51-63, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. **Immunodeficiency associated with a novel functionally defective variant of SLC19A1 benefits from folinic acid treatment**

Gök V., Erdem Ş., Haliloğlu Y., Bişgin A., Belkaya S., Başaran K. E., et al.

GENES AND IMMUNITY , cilt.24, sa.1, ss.12-20, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3β-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent

ŞENOL H., Ozgun-Acar O., DAĞ A., EKEN A., GÜNER H., Aykut Z. G., et al.

Journal of Natural Products , cilt.86, sa.1, ss.103-118, 2023 (SCI-Expanded, Scopus)

26. Oxidative and chromosomal DNA damage in patients with type I Gaucher disease and carriers

Uzen R., Bayram F., Dursun H., Kardas F., Altın-Celik P., Cakir M., et al.

CLINICAL BIOCHEMISTRY , cilt.111, ss.26-31, 2023 (SCI-Expanded, Scopus)

27. Suspected ALPS with clinical and laboratory findings: Three patients-three different diagnoses

Karakurt T., Kasap N., ASLAN K., BEKİS BOZKURT H., Cetinkaya F. B., Uslu G., et al.

AIMS ALLERGY AND IMMUNOLOGY , cilt.7, sa.4, ss.304-312, 2023 (ESCI)

28. A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™)

GÜL F., GÖNEN Z. B., Jones O. Y., Taşlı N. P., ZARARSIZ G., ÜNAL E., et al.

FRONTIERS IN IMMUNOLOGY , cilt.13, 2022 (SCI-Expanded, Scopus)

29. Characterization of cord blood CD3⁺TCRVα7.2⁺CD161^high T and innate lymphoid cells in the pregnancies with gestational diabetes, morbidly adherent placenta, and pregnancy hypertension diseases

Haliloglu Y., Ozcan A., Erdem S., Azizoglu Z. B., Bicer A., Ozarslan Ö. Y., et al.

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY , cilt.88, sa.1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis.

Kasap N., Aslan K., Karakurt L. T., Bozkurt H., Canatan H., Cavkaytar O., et al.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , cilt.52, sa.7, ss.907-910, 2022 (SCI-Expanded, Scopus)

31. A novel missense mutation outside the DNAJ domain of DNAJC21 is associated with Shwachman-Diamond syndrome

Alsavaf M. B., Verboon J. M., DOĞAN M. E., Azizoglu Z. B., Okus F. Z., ÖZCAN A., et al.

BRITISH JOURNAL OF HAEMATOLOGY , cilt.197, sa.6, 2022 (SCI-Expanded, Scopus)

32. S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo

Zehra Okus F., Busra Azizoglu Z., CANATAN H., EKEN A.

International Immunopharmacology , cilt.107, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency

Kocamış B., Baser D., Akcam B., Danielson J., Eltan S. B., Haliloglu Y., et al.

ALLERGY , cilt.77, sa.3, ss.1004-1019, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. The Effect of Exercise and Mesenchymal Stem Cell Applications on Blood Profile in Rats with Sciatic Nerve Damage

Ozocak O., Kestane S., Aktoprak M., ÇOKSEVİM B., YÜRÜK M., EKEN A.

ACTA PHYSIOLOGICA , cilt.234, ss.86, 2022 (SCI-Expanded, Scopus)

35. Development of a three dimensional (3D) knitted scaffold for myocardial tissue engineering. Part II: biological performance of the knitted scaffolds

HAROĞLU D., EKEN A., GÖNEN Z. B., BAHAR D.

Journal of the Textile Institute , cilt.113, sa.5, ss.895-905, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Circulating Fibrocyte Level in Children with Cystic Fibrosis.

Yaşar P. A., Köse M., Erdem S., Hangül M., Karaman F., Eken A.

Pediatrics international : official journal of the Japan Pediatric Society , cilt.64, 2022 (SCI-Expanded, Scopus)

37. A Novel Intronic Mutation Reduces HAX1 Level and is Associated With Severe Congenital Neutropenia.

Goktas S., Azizoglu Z. B., Petersheim D., Erdogan M., Eke Gungor H., Bisgin A., et al.

Journal of pediatric hematology/oncology , cilt.44, 2022 (SCI-Expanded, Scopus)

38. A NOVEL MISSENSE MUTATION OUTSIDE DNAJ DOMAIN OF DNAJC21 IS ASSOCIATED WITH SHWACHMAN-DIAMOND SYNDROME

Alsavaf M. B., Verboon J. M., Dogan M. E., Azizoglu Z. B., Okus F. Z., Ozcan A., et al.

Hematology, Transfusion and Cell Therapy , cilt.43, sa.3, ss.61-62, 2021 (Scopus)

39. A NOVEL MUTATION IN DIACYLGLYCEROL KINASE EPSILON GENE CAUSING STEROID RESISTANT NEPHROTIC SYNDROME

GÜNAY N., PINARBAŞI A. S., Dogan M. E., YEL S., GENCER BALABAN A., DURSUN İ., et al.

PEDIATRIC NEPHROLOGY , cilt.36, sa.10, ss.3477-3478, 2021 (SCI-Expanded, Scopus)

40. Immunomagnetic separation of B type acute lymphoblastic leukemia cells from bone marrow with flow cytometry validation and microfluidic chip measurements

İçöz K., Eken A., Cinar S., Murat A., Özcan S., Ünal E., et al.

SEPARATION SCIENCE AND TECHNOLOGY , cilt.56, sa.15, ss.2659-2666, 2021 (SCI-Expanded, Scopus)

41. Temporal overexpression of IL-22 and Reg3 gamma differentially impacts the severity of experimental autoimmune encephalomyelitis

Eken A., Erdem S., Haliloglu Y., Okus F. Z., Cakir M., Yetkin M. F., et al.

IMMUNOLOGY , cilt.164, sa.1, ss.73-89, 2021 (SCI-Expanded, Scopus)

42. A nonsense mutation in DIAPH1 gene presents with major T cell defects

Azizoglu Z. B., Okus F. Z., ÖZCAN A., Sawaf B., KÖSE M., CANÖZ Ö., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.51, ss.296, 2021 (SCI-Expanded, Scopus)

43. Characterization of regulatory T cells in the IDH1 mutant and wild type glioblastoma tumor microenvironment

Haliloglu Y., Erdem S., ULUTABANCA H., KÜÇÜK A., EKEN A., CANATAN H.

EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.51, ss.202, 2021 (SCI-Expanded, Scopus)

44. Teriflunomide ameliorates disease severity and immunopathology of experimental autoimmune myasthenia gravis induced by acetylcholine receptor immunizations in mice

KÖSEOĞLU E., SUNGUR N., MUHTAROĞLU S., EKEN A.

EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.51, ss.418, 2021 (SCI-Expanded, Scopus)

45. Characterization of Th17 and Treg cells in leucocyte adhesion deficiency 1 patients

Erdem S., Haliloglu Y., Haskaloglu S., Arik E., KESKİN Ö., Karadag S. I. K., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.51, ss.298, 2021 (SCI-Expanded, Scopus)

46. The number and activity of CD3(+)TCR V alpha 7.2(+)CD161(+) cells are increased in children with acute rheumatic fever

Ozkaya M., Baykan A., Cakir M., Vural C., Sunkak S., Unal E., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.333, ss.174-183, 2021 (SCI-Expanded, Scopus)

47. Common Variable Immunodeficiency, Autoimmune Hemolytic Anemia, and Pancytopenia Associated With a Defect in IKAROS

Yilmaz E., Kuehn H., Odakir E., Niemela J., Ozcan A., Eken A., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , sa.3, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. A rare cause of membranoproliferative patterns of injury in siblings with steroid-resistant nephrotic syndrome: Questions

Günay N., Pınarbaşı A. S., Doğan M. E., Yel S., Balaban A. G., Dursun İ., et al.

PEDIATRIC NEPHROLOGY , cilt.36, sa.12, ss.4027-4028, 2020 (SCI-Expanded, Scopus)

49. A rare cause of membranoproliferative patterns of injury in siblings with steroid-resistant nephrotic syndrome: Answers

Günay N., Pınarbaşı A. S., Doğan M. E., Yel S., Balaban A. G., Dursun İ., et al.

PEDIATRIC NEPHROLOGY , sa.12, ss.4029-4032, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?

AVCILAR H., Eken A.

MEDICAL HYPOTHESES , cilt.144, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Impact of Intrauterine Growth Restriction Diseases on The Umbilical Cord Blood CD34 Cell Counts

Türkoglu E. M., Erdem S., Bicer A., Okus F. Z., ÖZCAN A., azizoglu z. B., et al.

Journal of Pediatric Academy , ss.51-56, 2020 (Hakemli Dergi)

52. ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients

Eken A., Cansever M., Okus F. Z., Erdem S., Nain E., Azizoglu Z. B., et al.

ALLERGY , cilt.75, sa.4, ss.921-933, 2020 (SCI-Expanded, Scopus)

53. The Effect of Alantolactone on the Development of Multiple Sclerosis

Çakır M., Karayiğit M. Ö., Eken A., Altuntaş H.

Proceedings , cilt.40, ss.16, 2019 (Hakemli Dergi)

54. The Effect of Schisandrin B on the Development of Multiple Sclerosis

Çakır M., Karayiğit M. Ö., Eken A., Altuntaş H.

Proceedings , cilt.40, ss.15, 2019 (Hakemli Dergi)

55. Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells

Eken A., Cansever M., Somekh I., Mizoguchi Y., Zietara N., Okus F., et al.

JOURNAL OF CLINICAL IMMUNOLOGY , cilt.39, sa.4, ss.391-400, 2019 (SCI-Expanded, Scopus)

56. IL-22 and Reg3γ Overexpression Affects Experimental Autoimmune Encephalomyelitis Severity

Eken A., Yetkin M. F., Okuş F. Z., Çakır M., Karayiğit M. Ö., Erdem Ş., et al.

Journal Of Immunology , cilt.202, sa.1, ss.19312, 2019 (SCI-Expanded, Scopus)

57. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells

EKEN A., YETKİN M. F., VURAL A., Okus F. Z., Erdem S., Azizoglu Z. B., et al.

FRONTIERS IN IMMUNOLOGY , cilt.10, 2019 (SCI-Expanded, Scopus)

58. The TYK2-P1104A Autoimmune Protective Variant Limits Coordinate Signals Required to Generate Specialized T Cell Subsets

GORMAN J. A., HUNDHAUSEN C., KINSMAN M., ARKATKAR T., ALLENSPACH E. J., CLOUGH C., et al.

FRONTIERS IN IMMUNOLOGY , cilt.10, 2019 (SCI-Expanded, Scopus)

59. IL-15 negatively regulates curdlan-induced IL-23 production by human monocyte-derived dendritic cells and subsequent Th17 response

EKEN A., Okus F. Z., Erdem S., Azizoglu Z. B., Haliloglu Y., Bicer A., et al.

NORTHERN CLINICS OF ISTANBUL , cilt.6, sa.4, ss.379-387, 2019 (ESCI, TRDizin)

60. DOCK8 regulates fitness and function of regulatory T cells through modulation of IL-2 signaling

Singh A. K., Eken A., Hagin D., Komal K., Bhise G., Shaji A., et al.

JCI INSIGHT , cilt.2, sa.19, 2017 (SCI-Expanded, Scopus)

61. Absence of functional fetal regulatory T cells in humans causes in utero organ-specific autoimmunity.

ALLENSPACH E., FINN L., RENDI M., Eken A., SINGH A., OUKKA M., et al.

The Journal of allergy and clinical immunology , cilt.140, 2017 (SCI-Expanded, Scopus)

62. Interleukin 23 in Crohn's Disease

Eken A., Singh A. K., Oukka M.

INFLAMMATORY BOWEL DISEASES , cilt.20, sa.3, ss.587-595, 2014 (SCI-Expanded, Scopus)

63. IL-23R(+) innate lymphoid cells induce colitis via interleukin-22-dependent mechanism

Eken A., Singh A. K., Treuting P. M., Oukka M.

MUCOSAL IMMUNOLOGY , cilt.7, sa.1, ss.143-154, 2014 (SCI-Expanded, Scopus)

64. Chronic alcohol-induced liver disease inhibits dendritic cell function

Feng D., Eken A., Ortiz V., Wands J. R.

LIVER INTERNATIONAL , cilt.31, sa.7, ss.950-963, 2011 (SCI-Expanded, Scopus)

65. Ethanol Inhibits Antigen Presentation by Dendritic Cells

Eken A., Ortiz V., Wands J. R.

CLINICAL AND VACCINE IMMUNOLOGY , cilt.18, sa.7, ss.1157-1166, 2011 (SCI-Expanded, Scopus)

66. Alcohol and Hepatitis C Virus-Interactions in Immune Dysfunctions and Liver Damage

Szabo G., Wands J. R., Eken A., Osna N. A., Weinman S. A., Machida K., et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH , cilt.34, sa.10, ss.1675-1686, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells

Wintermeyer P., Gehring S., Eken A., Wands J. R.

JOURNAL OF VIRAL HEPATITIS , cilt.17, sa.10, ss.705-713, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 34

1. ÇOCUKLUK ÇAĞI Β-TALASEMİ MAJÖR HASTALARINDA HASAR İLİŞKİLİ MOLEKÜLER PATERNLERDEN NÜKLEİK ASİT SENSÖRLERİNDE İMMUN DİSREGULASYON MEVCUTTUR

Houran M., Demir B. Ş., TAV N., ERDEM Ş., Aşan M., Kendirli P. K., et al.

16. Ulusal Pediatrik Hematoloji Kongresi, İzmir, Türkiye, 8 - 11 Mayıs 2025, (Özet Bildiri)

2. İNAKTİF COVID-19 AŞISI TURKOVAC’IN UZUN SÜRELİ BAĞIŞIKLIK ETKİLERİ: SPIKE PROTEİNİNE ÖZGÜ B HÜCRE YANITLARININ KARAKTERİZASYONU

BAĞCI B. Ş., YILMAZ S., EKEN A., ERDEM Ş., Doğan Sarıkaya M., SEZER Z., et al.

5. Uluslararası Aşı Bilimi Kongresi, Kayseri, Türkiye, 16 - 18 Ekim 2024, ss.61, (Özet Bildiri)

3. TURKOVAC İNAKTİF COVID-19 AŞISININ HÜCRESEL VE HUMORAL BAĞIŞIKLIK HAFIZASI ÜZERİNDEKİ UZUN DÖNEM ETKİLERİNİN ARAŞTIRILMASI

BAĞCI B. Ş., YILMAZ S., EKEN A., ERDEM Ş., Doğan Sarıkaya M., SEZER Z., et al.

5. Uluslararası Aşı Bilimi Kongresi, Kayseri, Türkiye, 16 - 18 Ekim 2024, ss.17, (Özet Bildiri)

4. Gramisidin A Biyosürfaktanının MCF-7 Meme Kanseri Hücre Dizisinde İnflamasyona Etkisinin Moleküler Düzeyde Araştırılması

Altın Çelik P., Eken A., Derya Andeden M., Üzen R., Altuntaş H.

2. Uluslararası Kapadokya Bilimsel Araştırmalar Kongresi, Nevşehir, Türkiye, 17 - 19 Haziran 2022, ss.1181-1182, (Özet Bildiri) Sürdürülebilir Kalkınma

5. PS-174-AKUT ROMATİZMAL ATEŞ HASTALARINDA İMMÜN EFEKTÖR HÜCRELER

Özkaya M., Baykan A., Eken A., Ünal E., Pamukçu Ö., Vural Ç., et al.

19.Ulusal pediatrik kardiyoloji ve pediatrik kalp cerrahisi sanal kongresi, 23 - 25 Ekim 2020, cilt.1, ss.343, (Tam Metin Bildiri)

6. Schisandrin B and Alantolactone ameliorates experimental autoimmune encephalomyelitis in mice

EKEN A., ÇAKIR M., KARAYİĞİT M. Ö., ALTUNTAŞ H.

The Journal of Immunology, 01 Mayıs 2020, cilt.204, ss.16012, (Tam Metin Bildiri)

7. The Effect of Alantolactone on the Development of Multiple Sclerosis

Çakır M., Karayiğit M. Ö., Eken A., Altuntaş H.

the 3rd International conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Türkiye, 18 - 20 Aralık 2019, cilt.40, sa.1, ss.16, (Özet Bildiri)

8. The Effect of Schisandrin B on the Development of Multiple Sclerosis

Çakır M., Karayiğit M. Ö., Eken A., Altuntaş H.

the 3rd International conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Türkiye, 18 - 20 Aralık 2019, cilt.40, sa.1, ss.15, (Özet Bildiri)

9. Reg3γ overekspresyonunun mürin deneysel otoimmün ensefalit (EAE) modeline etkileri

EKEN A.

Uluslararası Tıp ve Sağlık Bilimleri Araştırmaları Kongresi’ni (UTSAK), Türkiye, 11 - 12 Temmuz 2019, (Özet Bildiri)

10. IL-22 and Reg3γ Overexpression Affects Experimental Autoimmune Encephalomyelitis Severity

EKEN A., YETKİN M. F., Okuş F. Z., ÇAKIR M., KARAYİĞİT M. Ö., erdem ş., et al.

The Journal of Immunology, 9 - 13 Mayıs 2019, cilt.1, ss.19312, (Özet Bildiri)

11. IL-22 and Reg3 gamma overexpression affects Experimental Autoimmune Encephalomyelitis Severity

Eken A., YETKİN M. F., Okus F. Z., Cakir M., Karayigit M. O., Erdem S., et al.

103rd Annual Meeting of the American-Association-of-Immunologists, California, Amerika Birleşik Devletleri, 9 - 13 Mayıs 2019, cilt.202, (Özet Bildiri)

12. S1P1 Agonisti SEW2871 insan Th17 Hücresi gelişim ve fonksiyonlarını doğrudan ve dolaylı etkilemektedir

EKEN A., Okus F. Z., YETKİN M. F., çakır m., ÖZDARENDELİ A., ALTUNTAŞ H., et al.

XXIV. Ulusal İmmünoloji Kongresi, Türkiye, 27 - 30 Nisan 2017, (Özet Bildiri)

13. IL-15 exposure reduces Th17-associated cytokine production by human monocyte derived dendritic cells

Eken A., Okuş F., Erdem Ş., Azizoğlu Z., Haliloğlu Y., Biçer A., et al.

International Molecular Immunology & Immunogenetics Congress IV (MIMIC IV), Bursa, Türkiye, 27 - 29 Nisan 2019, ss.132, (Özet Bildiri)

14. Characterization of Treg cells generated in the presence of group 3 innate lymphoid cells ex vivo

Eken A., Okuş F., Erdem Ş., Azizoğlu Z., Haliloğlu Y., Biçer A., et al.

International Molecular Immunology & Immunogenetics Congress IV (MIMIC IV), Bursa, Türkiye, 27 - 29 Nisan 2019, ss.40, (Özet Bildiri)

15. Characterization of Treg cells generated in the presence of group 3 innate lymphoid cells

EKEN A.

3. Kok Hucre ve Hucresel Tedaviler Kongresi-ISSCA, 12 - 14 Nisan 2019, (Özet Bildiri)

16. IL-15’İN İNSAN DENDRİTİK HÜCRELERİ TARAFINDAN IL-23ÜRETİMİNE ETKİLERİ

EKEN A.

IAMHC 1 st International Ahi Evran Medicine Health Science Congress, 11 - 14 Nisan 2019, (Özet Bildiri)

17. FİNGOLİMODUN, İNSAN VE FARELERDE İNNATE LENFOİD HÜCRELERİN DOKU DAĞILIMI VE SİTOKİN ÜRETİMİNE ETKİSİ

YETKİN M. F., EKEN A., VURAL A., Okuş F., ALTUNTAŞ H., Erdem Ş., et al.

54. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 1 - 05 Aralık 2018, ss.469, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

18. S1P1 receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology

EKEN A., YETKİN M. F., VURAL A., Okuş F. Z., CANATAN H., ALTUNTAŞ H., et al.

ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Almanya, 10 - 12 Ekim 2018, ss.762, (Tam Metin Bildiri)

19. Group 3 innate lymhoid cells are absent in DOCK8-defective HIES patients

Eken A., Okus F. Z., Patiroglu T., Erdem S., Karakukcu M., Cansever M., et al.

Annual Meeting of the American-Association-of-Immunologists (AAI), Texas, Amerika Birleşik Devletleri, 4 - 08 Mayıs 2018, cilt.200, (Özet Bildiri)

20. Group 3 Innate Lymphoid Cells in DOCK8 Deficiency: From Mice to Human

EKEN A., Okuş F., PATIROĞLU T., Erdem Ş., KARAKÜKCÜ M., CANSEVER M., et al.

Işıl Barlan İmmün Yetmezlikler Sempozyumu, İstanbul, Türkiye, 19 - 20 Nisan 2018, (Tam Metin Bildiri)

21. Dedicator of cytokinesis 8 defektif hastalarda grup 3 innate lenfoid hücreleri eksikliği mevcuttur

EKEN A., Okuş F., PATIROĞLU T., Erdem Ş., KARAKÜKCÜ M., CANSEVER M., et al.

4. Klinik İmmunoloji Kongresi, Antalya, Türkiye, 11 - 14 Nisan 2018, (Özet Bildiri)

22. Fingolimod ve SEW2871 insan Th17 hücresi gelişimini etkilemektedir

YETKİN M. F., EKEN A., Okuş F., ÇAKIR M., ÖZDARENDELİ A., ALTUNTAŞ H., et al.

10.Klinik Nöroimmunoloji Sempozyumu, Girne, Kıbrıs (Kktc), 1 - 05 Nisan 2018, ss.34, (Özet Bildiri)

23. Sphingosine 1 Fosfat Reseptörü-1 Agonistleri Fingolimod Ve SEW2871 İnnate Lenfoid Hücrelerin Biyolojisini Etkilemektedir

EKEN A., YETKİN M. F., Okus F. Z., Erdem S., çakır m., VURAL A., et al.

Kıbrıs, 10.Klinik Nöroimmünoloji Sempozyumu, 2018Nisan 1-4,, 1 - 04 Nisan 2018, (Özet Bildiri)

24. Sphingosine 1 phosphate 1 receptor agonists Fingolimod and SEW2871 impact innate lymphoid cell biology.

EKEN A., YETKİN M. F., Okuş F. Z., Erdem S., ÇAKIR M., KÜTÜK M. S., et al.

The World Immune Regulation Meeting XII (WIRM XII) kongresi, Davos, İsviçre, 14 - 17 Mart 2018, ss.46, (Tam Metin Bildiri)

25. Absence of group 3 innate Iymphoid cells in DOCK8- defective HIES patients

EKEN A., PATIROĞLU T., Okuş F. Z., Erdem Ş., KARAKÜKCÜ M., Cansever M., et al.

The World Immune Regulation Meeting XII (WIRM XII) kongresi, Davos, İsviçre, 14 - 17 Mart 2018, ss.66, (Tam Metin Bildiri)

26. S1P1 Agonist SEW2871 Inhibits human Th17 cell generation and functions

EKEN A., Okus F. Z., YETKİN M. F., ÇAKIR M., ÖZDARENDELİ A., MİRZA M.

IMMUNOLOGY2017, Washington Dc, Amerika Birleşik Devletleri, 12 - 16 Mayıs 2017, cilt.198, (Özet Bildiri)

27. IL-15 regulates IL-23 production and murine IBD-like disease

EKEN A., Singh A. K., Fry M., Bhise G., Bettelli E., Oukka M.

IMMUNOLOGY2017, Washington Dc, Amerika Birleşik Devletleri, 12 - 16 Mayıs 2017, cilt.198, (Özet Bildiri)

28. Direct and indirect effects of S1P1 Agonist SEW2871 on human Th17 cell generation and functions

EKEN A., Okuş F., YETKİN M. F., ÇAKIR M., ÖZDARENDELİ A., ALTUNTAŞ H., et al.

Erciyes Tıp Genetik Günleri, Kayseri, Türkiye, 11 - 15 Mayıs 2017, (Tam Metin Bildiri)

29. S1P1 Agonist SEW2871 Inhibits human Th17 cell generation and functions

Eken A., Okus F. Z., Yetkin M. F., Cakir M., Ozdarendeli A., Mirza M.

Annual Meeting of the American-Association-of-Immunologists (AAI), Washington, Kiribati, 12 - 16 Mayıs 2017, cilt.198, (Özet Bildiri)

30. S1P1 Agonisti SEW2871’in insan Th17 hücresi gelişim ve fonksiyonlarını doğrudan ve dolaylı etkilemektedir

EKEN A., Okuş F., YETKİN M. F., ÇAKIR M., ÖZDARENDELİ A., ALTUNTAŞ H., et al.

XXIV. Ulusal İmmunoloji Kongresi, İstanbul, Türkiye, 27 - 30 Nisan 2017, (Özet Bildiri)

31. Investigation of potential neurotoxic effects of perfluorooctanoic acid in Balb/c mice by evaluating oxidative stress induction and possible protective effects of taurine and coenzyme Q10 in this model system

Endirlik B., Özger E., EKEN A., ÖZTÜRK F., GÜRBAY A.

52nd Congress of the European-Societies-of-Toxicology (EUROTOX), Sevilla, İspanya, 4 - 07 Eylül 2016, cilt.258, (Özet Bildiri)

32. S1P(1) deletion differentially affects TH17 and regulatory T cells

EKEN A., DUHEN R., Singh A. K., FRY M., BUCKNER J. H., KITA M., et al.

International Congress of Immunology (ICI), Melbourne, Avustralya, 21 - 26 Ağustos 2016, cilt.46, ss.894, (Özet Bildiri)

33. DOCK8 regulates protective immunity by controlling the function and survival of ROR gamma t(+) ILCs

SINGH A., Eken A., FRY M., Bettelli E., Oukka M.

Annual Meeting of the American-Association-of-Immunologists (IMMUNOLOGY), Louisiana, Amerika Birleşik Devletleri, 8 - 12 Mayıs 2015, cilt.194, (Özet Bildiri)

34. CHRONIC ALCOHOL-INDUCED LIVER DISEASE ROLE IN THE INHIBITION OF DENDRITIC CELL FUNCTION

Feng D., Eken A., Ortiz V., Wands J. R.

62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 4 - 08 Kasım 2011, cilt.54, (Özet Bildiri)

Kitaplar 7

Ansiklopedide Bölümler 1

1. Encyclopedia of Inflammatory Diseases

EKEN A.

Springer Basel / Birkhäuser Basel, ss.1-10, 2015

Metrikler

Yayın

132

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

457

H-İndeks (WoS)

Atıf (Scopus)

631

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (Diğer Toplam)

Proje

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (Diğer Toplam)

Proje

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim